Latest news

An interview of Dr. Andrea Spezzi by UCL Innovation Forum

Orchard Therapeutics Limited (“Orchard”), today announces that the UK Medicines and Healthcare Products Regulatory Agency (“MHRA”) granted a Promising Innovative Medicine Designation to OTL-101

Orchard Therapeutics today announces the appointment of Mark Rothera as President and Chief Executive Officer.